# Heart Disease in Pregnancy

> Heart disease in pregnancy refers to **any structural, functional, or rhythm-related cardiovascular disorder** present before or developed during pregnancy, potentially affecting maternal and fetal outcomes.

## Types of Heart Disease in Pregnancy

1. **Congenital Heart Diseases (CHD)**

   - Atrial septal defect
   - Ventricular septal defect
   - Patent ductus arteriosus
   - Tetralogy of Fallot
   - Eisenmenger syndrome
   - Transposition of great arteries

2. **Acquired Heart Diseases**

   - **Rheumatic heart disease (RHD)**

     - Most common in developing countries
     - Common valvular lesions: Mitral stenosis, Aortic stenosis

   - **Ischemic heart disease (IHD)**

     - Rare, increasing due to older maternal age

   - **Cardiomyopathies**

     - Peripartum cardiomyopathy
     - Dilated/hypertrophic cardiomyopathy

   - **Endocarditis, myocarditis**

3. **Arrhythmias**

   - Atrial fibrillation
   - Supraventricular tachycardia

4. **Pulmonary Hypertension**

## Risk Factors

- History of rheumatic fever
- Family history of congenital heart disease
- Connective tissue disorders (e.g. Marfan’s)
- Prior cardiac surgery or intervention
- Maternal diabetes (for fetal CHD)
- Substance abuse (e.g. cocaine, alcohol)

## Effect of Pregnancy on Heart Disease

- ↑ Blood volume (40–50%) → ↑ preload
- ↑ Cardiac output (30–50%) → ↑ workload
- ↓ Systemic vascular resistance
- Hypercoagulable state → ↑ risk of thromboembolism
- Tachycardia and anaemia may worsen symptoms
  → Can precipitate heart failure, arrhythmias, or embolic events

## Effect of Heart Disease on Pregnancy

### Maternal

- **Heart failure**
- **Arrhythmias**
- **Thromboembolism**
- **Endocarditis**
- **Maternal mortality** (especially NYHA III–IV or pulmonary hypertension)

### Fetal

- **IUGR**
- **Preterm birth**
- **Stillbirth**
- **Neonatal death**
- **Congenital heart disease (if maternal CHD)**

## Investigations

### For Diagnosis

- **Echocardiography** – EF%, valvular lesions, pulmonary pressure
- **ECG** – Rhythm, hypertrophy, ischemia
- **Chest X-ray (with shielding)** – Cardiomegaly, pulmonary edema

### For Causes

- ASO titre, ESR, CRP (if RHD suspected)
- Blood cultures (if endocarditis suspected)

### For Complications

- CBC (anemia), BNP (heart failure), coagulation profile
- Oxygen saturation
- Fetal monitoring – growth scan, Doppler studies, NST

## Management

### Pre-Conception

1. **Risk Stratification**

   - Use **WHO risk classification**

     - WHO I (low risk) → Normal care
     - WHO IV (very high risk) → Pregnancy contraindicated

2. **Pre-pregnancy counselling**

   - Risk of maternal complications
   - Inheritance risk of CHD to offspring
   - Medication review: Stop teratogenic drugs
   - Optimize cardiac status: surgical repair if needed

3. **Contraceptive advice** if pregnancy not advised

   - Prefer **progesterone-only methods** or **IUD**
   - Avoid estrogen due to thrombogenic risk

### Antenatal (AN) Care

- **Multidisciplinary care**: Obstetrician + Cardiologist + Anaesthetist

- **Frequent visits** – Monthly to biweekly depending on severity

- **Monitoring**

  - Symptoms: Dyspnoea, fatigue, orthopnea
  - Signs: Murmur changes, edema, arrhythmias
  - Fetal growth scans every 4 weeks if high risk

- **Medications**

  - **Diuretics** (e.g. Furosemide 20–40 mg IV/PO) → If signs of fluid overload
  - **Beta-blockers** (e.g. Metoprolol 25–100 mg PO/day) → Control HR, arrhythmias
  - **Digoxin** (0.125–0.25 mg/day PO) → For rate control in AF
  - **Anticoagulation**

    - **Mechanical valve**:

      - 1st trimester: LMWH (e.g. Enoxaparin 1 mg/kg SC BD) or dose-adjusted warfarin
      - 2nd trimester: Warfarin preferred if dose \<5 mg/day
      - 3rd trimester: Switch to LMWH or UFH to avoid fetal bleeding

    - Monitor Anti-Xa or INR

- **Avoid** ACE inhibitors, ARBs, statins – teratogenic

### Intrapartum Care

#### 1st Stage (Place, Time, Mode)

- **Place**: Tertiary care with ICU & cardiac facilities
- **Time**: Elective induction at 38–39 weeks if stable
- **Mode**: Vaginal delivery preferred unless obstetric indication for LSCS

#### Labour Management

- **Strict monitoring**

  - O2 sat, ECG, BP, CVP if needed
  - Avoid fluid overload
  - Left lateral position

- **Analgesia**: Early epidural → ↓ stress, ↓ preload
- **Antibiotic prophylaxis** for infective endocarditis (controversial, consider if prosthetic valve or past endocarditis)

#### 2nd Stage

- Shorten second stage using **assisted vaginal delivery** (vacuum/forceps) to avoid Valsalva

#### 3rd Stage

- **Avoid ergometrine** → Can cause hypertension/tachycardia
- Use **oxytocin infusion (10–20 units in 500 mL over 4–6 hrs)**
- Watch for **sudden increase in venous return** after placenta delivery → precipitate failure

### Postpartum Care (Puerperium)

- **Highest risk for cardiac decompensation** in first 24–72 hrs postpartum
- **Monitoring in HDU/ICU**
- Gradual mobilization
- Continue heart failure medications
- **Contraceptive counselling**

  - Avoid combined pills
  - Progestin-only or non-hormonal preferred

## Maternal & Fetal Complications

### Maternal

- Heart failure
- Arrhythmias
- Endocarditis
- Thromboembolism
- Death

### Fetal

- IUGR
- Prematurity
- Stillbirth
- Neonatal CHD
